Thelansis

  Progressive familial intrahepatic cholestasis (PFIC) is inherited condition that affects the liver. In PFIC, children are not able to drain bile from the liver even though the large bile ducts are open (cholestasis). Mutations in the ATP8B1, ABCB11, and ABCB4 genes cause PFIC1, PFIC2 and PFIC3, respectively. Some people with PFIC do not have a mutation in the ATP8B1, ABCB11, or ABCB4 gene. PFIC is estimated to affect 1 in 50,000 to 100,000 people worldwide. PFIC type 1 is much more common in the Inuit population of Greenland and the Old Order Amish population of the United States. Thelansis’s “Progressive Familial Intrahepatic Cholestasis (PFIC) Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights ...